Results showed significant downregulation of all analyzed proteins in media-treated ALS mice versus controls: ZO-1 (p = 0.001), occludin (p = 0.001), and claudin-5 (p = 0.024; Fig. 1). The gene discussed is CLDN5; the disease is amyotrophic lateral sclerosis.